Exome Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-32,900
Closed -$5.2M 78
2024
Q2
$5.2M Buy
+32,900
New +$5.2M 4.63% 2